[image_with_animation image_url=”8185″ alignment=”” animation=”None” border_radius=”none” box_shadow=”none” max_width=”100%”]

Josh Feldstein

CEO

[divider line_type=”No Line” custom_height=”20″]

Past Topics

[divider line_type=”Full Width Line” line_thickness=”1″ divider_color=”default” custom_height=”15″][fancy-ul icon_type=”standard_dash” color=”Accent-Color” alignment=”left”]

  • Economic Panel
    • Webcast Summit May 2020

[/fancy-ul]

Josh Feldstein is an applied health economist with a specialization in surgical robotics and robotic program optimization; an educator in robotic cost-effectiveness and related data analytics; a strategic business and market advisor to the US and international hospital and medical-surgical industries; and a published healthcare author and editor. Mr. Feldstein has designed and deployed groundbreaking, online cost-effectiveness analytic modeling and change management solutions in robotic surgery program design for hospitals and IDNs and for numerous other medical-surgical devices and pharmaceuticals. For more than 25 years, he has served the US and global hospital, medical-surgical device, and pharmaceutical industries, having managed hundreds of programs in the US and in more than a dozen countries globally. Mr. Feldstein serves as Pharmacoeconomics Editor of American Health and Drug Benefits. He received his BA cum laude from Queens College, CUNY, and has completed masters studies at Fairfield University and Andrew Jackson University.